annual D&A:
$2.56M+$499.00K(+24.21%)Summary
- As of today (July 1, 2025), XENE annual depreciation & amortization is $2.56 million, with the most recent change of +$499.00 thousand (+24.21%) on December 31, 2024.
- During the last 3 years, XENE annual D&A has risen by +$1.65 million (+182.56%).
- XENE annual D&A is now at all-time high.
Performance
XENE Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$659.00K+$26.00K(+4.11%)Summary
- As of today (July 1, 2025), XENE quarterly depreciation & amortization is $659.00 thousand, with the most recent change of +$26.00 thousand (+4.11%) on March 31, 2025.
- Over the past year, XENE quarterly D&A has increased by +$73.00 thousand (+12.46%).
- XENE quarterly D&A is now -62.00% below its all-time high of $1.73 million, reached on September 30, 2023.
Performance
XENE quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.63M+$73.00K(+2.85%)Summary
- As of today (July 1, 2025), XENE TTM depreciation & amortization is $2.63 million, with the most recent change of +$73.00 thousand (+2.85%) on March 31, 2025.
- Over the past year, XENE TTM D&A has increased by +$340.00 thousand (+14.83%).
- XENE TTM D&A is now -11.82% below its all-time high of $2.99 million, reached on September 30, 2023.
Performance
XENE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XENE Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | +12.5% | +14.8% |
| 3 y3 years | +182.6% | +75.3% | +142.4% |
| 5 y5 years | +496.7% | +533.6% | +405.4% |
XENE Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +182.6% | -62.0% | +204.8% | -11.8% | +114.1% |
| 5 y | 5-year | at high | +496.7% | -62.0% | +204.8% | -11.8% | +405.4% |
| alltime | all time | at high | +496.7% | -62.0% | +204.8% | -11.8% | +1404.6% |
XENE Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $659.00K(+4.1%) | $2.63M(+2.9%) |
| Dec 2024 | $2.56M(+24.2%) | $633.00K(-5.4%) | $2.56M(+97.2%) |
| Sep 2024 | - | $669.00K(-0.4%) | $1.30M(-45.1%) |
| Jun 2024 | - | $672.00K(+14.7%) | $2.36M(+3.1%) |
| Mar 2024 | - | $586.00K(-193.2%) | $2.29M(+11.3%) |
| Dec 2023 | $2.06M(+46.7%) | -$629.00K(-136.3%) | $2.06M(-31.0%) |
| Sep 2023 | - | $1.73M(+188.0%) | $2.99M(+85.5%) |
| Jun 2023 | - | $602.00K(+70.1%) | $1.61M(+16.4%) |
| Mar 2023 | - | $354.00K(+19.6%) | $1.38M(-1.6%) |
| Dec 2022 | $1.41M(+55.1%) | $296.00K(-17.3%) | $1.41M(+1.9%) |
| Sep 2022 | - | $358.00K(-4.5%) | $1.38M(+12.1%) |
| Jun 2022 | - | $375.00K(-0.3%) | $1.23M(+13.3%) |
| Mar 2022 | - | $376.00K(+39.3%) | $1.09M(+19.9%) |
| Dec 2021 | $906.00K(+40.7%) | $270.00K(+29.2%) | $906.00K(+8.1%) |
| Sep 2021 | - | $209.00K(-9.5%) | $838.00K(+4.8%) |
| Jun 2021 | - | $231.00K(+17.9%) | $800.00K(+8.7%) |
| Mar 2021 | - | $196.00K(-3.0%) | $736.00K(+14.3%) |
| Dec 2020 | $644.00K(+50.1%) | $202.00K(+18.1%) | $644.00K(+9.5%) |
| Sep 2020 | - | $171.00K(+2.4%) | $588.00K(+12.9%) |
| Jun 2020 | - | $167.00K(+60.6%) | $521.00K(+14.8%) |
| Mar 2020 | - | $104.00K(-28.8%) | $454.00K(+5.8%) |
| Dec 2019 | $429.00K | $146.00K(+40.4%) | $429.00K(+1.2%) |
| Sep 2019 | - | $104.00K(+4.0%) | $424.00K(-8.4%) |
| Jun 2019 | - | $100.00K(+26.6%) | $463.00K(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $79.00K(-44.0%) | $515.00K(-12.1%) |
| Dec 2018 | $586.00K(-9.7%) | $141.00K(-1.4%) | $586.00K(-1.0%) |
| Sep 2018 | - | $143.00K(-5.9%) | $592.00K(-4.1%) |
| Jun 2018 | - | $152.00K(+1.3%) | $617.00K(-2.7%) |
| Mar 2018 | - | $150.00K(+2.0%) | $634.00K(-2.3%) |
| Dec 2017 | $649.00K(-24.9%) | $147.00K(-12.5%) | $649.00K(-2.8%) |
| Sep 2017 | - | $168.00K(-0.6%) | $668.00K(+0.1%) |
| Jun 2017 | - | $169.00K(+2.4%) | $667.00K(-10.7%) |
| Mar 2017 | - | $165.00K(-0.6%) | $747.00K(-13.5%) |
| Dec 2016 | $864.00K(-16.8%) | $166.00K(-0.6%) | $864.00K(-12.0%) |
| Sep 2016 | - | $167.00K(-32.9%) | $982.00K(-8.8%) |
| Jun 2016 | - | $249.00K(-11.7%) | $1.08M(-3.2%) |
| Mar 2016 | - | $282.00K(-0.7%) | $1.11M(+7.2%) |
| Dec 2015 | $1.04M(+40.7%) | $284.00K(+8.4%) | $1.04M(+8.2%) |
| Sep 2015 | - | $262.00K(-8.1%) | $959.00K(+9.0%) |
| Jun 2015 | - | $285.00K(+37.7%) | $880.00K(+14.3%) |
| Mar 2015 | - | $207.00K(+1.0%) | $770.00K(+4.3%) |
| Dec 2014 | $738.00K(+4.7%) | $205.00K(+12.0%) | $738.00K(+38.5%) |
| Sep 2014 | - | $183.00K(+4.6%) | $533.00K(+52.3%) |
| Jun 2014 | - | $175.00K(0.0%) | $350.00K(+100.0%) |
| Mar 2014 | - | $175.00K | $175.00K |
| Dec 2013 | $705.00K(-10.3%) | - | - |
| Dec 2012 | $786.00K(-30.6%) | - | - |
| Dec 2011 | $1.13M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual D&A year-on-year change?
- What is Xenon Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
- What is Xenon Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM D&A year-on-year change?
What is Xenon Pharmaceuticals annual depreciation & amortization?
The current annual D&A of XENE is $2.56M
What is the all time high annual D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual depreciation & amortization is $2.56M
What is Xenon Pharmaceuticals annual D&A year-on-year change?
Over the past year, XENE annual depreciation & amortization has changed by +$499.00K (+24.21%)
What is Xenon Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of XENE is $659.00K
What is the all time high quarterly D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly depreciation & amortization is $1.73M
What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, XENE quarterly depreciation & amortization has changed by +$73.00K (+12.46%)
What is Xenon Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of XENE is $2.63M
What is the all time high TTM D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM depreciation & amortization is $2.99M
What is Xenon Pharmaceuticals TTM D&A year-on-year change?
Over the past year, XENE TTM depreciation & amortization has changed by +$340.00K (+14.83%)